| 000 | 01220 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250514001916.0 | ||
| 264 | 0 | _c20010726 | |
| 008 | 200107s 0 0 eng d | ||
| 022 | _a0250-7005 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCuline, S | |
| 245 | 0 | 0 |
_a5-fluorouracil and leucovorin as second-line chemotherapy in carcinomas of unknown primary site. _h[electronic resource] |
| 260 |
_bAnticancer research _c |
||
| 300 |
_a1455-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeucovorin _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms, Unknown Primary _xdrug therapy |
| 650 | 0 | 4 |
_aSalvage Therapy _xmethods |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aYchou, M | |
| 700 | 1 | _aFabbro, M | |
| 700 | 1 | _aRomieu, G | |
| 700 | 1 | _aCupissol, D | |
| 773 | 0 |
_tAnticancer research _gvol. 21 _gno. 2B _gp. 1455-7 |
|
| 999 |
_c11326815 _d11326815 |
||